What is PWG’s main focus area?
PWG focuses on R&D activities targeting artificial organs to treat incurable diseases using cutting-edge genetics technology. It produces and supplies SPF (Specific Pathogen-free) Micro-pigs for research on various diseases. The company also provides CRO (contract research organization) services under GLP environment and develops various models of Micro-pigs for different types of research. One of our main biomedical products is for the treatment of islet cells for diabetes patient. This treatment is designed to solve the problem of shortage of organ donors, PWG Islet Cells are pancreatic islet cells extracted from pathogen-free Micro-pigs for xenotransplant into the human body. We are also developing the treatment for regenerating tissues and transgenic animal disease models for medical research. How would you describe the current market for animal-based research? With biomedical and biotechnology research taking prominence in many countries worldwide, there will be an increasing mark
